Zobrazeno 1 - 10
of 85
pro vyhledávání: '"Hanguang Hu"'
Autor:
Xuefeng Fang, Chenhan Zhong, Shanshan Weng, Hanguang Hu, Jian Wang, Qian Xiao, Jianwei Wang, Lifeng Sun, Dong Xu, Xiujun Liao, Caixia Dong, Suzhan Zhang, Jun Li, Kefeng Ding, Ying Yuan
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Background Rat sarcoma viral oncogene homolog (RAS) gene mutation is a common molecular event in colorectal cancer (CRC). The prognosis of mCRC (metastatic colorectal cancer) patients with RAS mutation is poor and capecitabine and oxaliplati
Externí odkaz:
https://doaj.org/article/647f7799d3cd440ab58ab7ab8867c19c
Autor:
Xuefeng Fang, Ning Zhu, Chenhan Zhong, Liuhong Wang, Jun Li, Shanshan Weng, Hanguang Hu, Caixia Dong, Dan Li, Yongmao Song, Dong Xu, Jianwei Wang, Lifeng Sun, Jian Wang, Zhanhuai Wang, Hongfeng Cao, Xiujun Liao, Ningjuan Yu, Qian Xiao, Mi Mi, Suzhan Zhang, Kefeng Ding, Ying Yuan
Publikováno v:
EClinicalMedicine, Vol 62, Iss , Pp 102123- (2023)
Summary: Background: Microsatellite stable (MSS) and RAS-mutant metastatic colorectal cancer (mCRC) patients are characterized by an immunosuppressive microenvironment and a low response rate to immunotherapy. Chemotherapy and anti-angiogenesis thera
Externí odkaz:
https://doaj.org/article/1b1658cdf06448d39ce387a707d64b2e
Autor:
Dongjun Dai, Dehao Wu, Runliang Ni, Ping Li, Zhifeng Tian, Yongjie Shui, Hanguang Hu, Qichun Wei
Publikováno v:
Frontiers in Molecular Biosciences, Vol 10 (2023)
Objectives: The goal of our bioinformatics study was to comprehensively analyze the association between the whole calpain family members and the progression and prognosis of hepatocellular carcinoma (HCC).Methods: The data were collected from The Can
Externí odkaz:
https://doaj.org/article/df1f71d005974b93a5c0f4f21ced4f31
Autor:
Yue Liu, Qian Xiao, Jinjie He, Hanguang Hu, Jinlin Du, Yuping Zhu, Jiaqi Chen, Zhuo Liu, Jianping Wang, Lifeng Sun, Dong Xu, Jun Li, Xiujun Liao, Jianwei Wang, Yibo Cai, Cheng Cai, Zhekang Jin, Liuhong Wang, Ying Yuan, Kefeng Ding
Publikováno v:
BMC Medicine, Vol 20, Iss 1, Pp 1-10 (2022)
Abstract Background Anlotinib, an oral small molecule tyrosine kinase inhibitor targeting VEGFR 1/2/3, FGFR 1-4, PDGFR a/β, and c-kit, had demonstrated prolonged progression-free survival (PFS) in refractory metastatic colorectal cancer (mCRC). This
Externí odkaz:
https://doaj.org/article/546bcd30f51940458ee15c2d1ec70809
Autor:
Jinjie He MD, Yue Liu PhD, Chengcheng Liu PhD, Hanguang Hu PhD, Lifeng Sun MD, Dong Xu MD, Jun Li MD, Junye Wang MD, Xiaobing Chen MD, Rongbo Lin MD, Yi Jiang MD, Yanqiao Zhang MD, Weisheng Zhang MD, Ying Cheng MD, Xiaohong Wu MD, Mingzhi Fang MD, Enxiao Li MD, Ye Xu MD, Ye Chen MD, Jiayi Li MD, Yanyan Cui MD, Zhanyu Pan MD, Songnan Zhang MD, Ying Yuan PhD, Kefeng Ding PhD
Publikováno v:
Technology in Cancer Research & Treatment, Vol 22 (2023)
Background: Chemotherapy combined with antivascular endothelial growth factor (VEGF) or anti-epidermal growth factor receptor monoclonal antibodies is the most promising approach to prolong survival and improve the quality of life of patients with un
Externí odkaz:
https://doaj.org/article/ea3bcbdb33614543aaa810bf80794bbf
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 7, Iss 1, Pp 1-3 (2022)
Externí odkaz:
https://doaj.org/article/33dbfce3c327453486b17e371beb87bf
Publikováno v:
Frontiers in Public Health, Vol 10 (2022)
BackgroundThe Coronavirus disease 2019 (COVID-19) has presented a major challenge to the health, economic, and social sectors of the entire world. This study aimed to investigate the mental health and academic performance of medical postgraduates dur
Externí odkaz:
https://doaj.org/article/da37a72f730b470399fbd09b0fb843c3
Publikováno v:
Cancer Medicine, Vol 9, Iss 3, Pp 971-979 (2020)
Abstract Neuroendocrine tumors (NETs) are heterogeneous, and the incidence of NETs is rapidly increasing. We observed different survival in patients with rectal NETs and rectosigmoid junction NETs, which are treated similarly. We included patients wi
Externí odkaz:
https://doaj.org/article/b108a9033447404386b783a366953d3f
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 14 (2021)
Background: Colonic neuroendocrine carcinomas (co-NECs) are heterogeneous and aggressive, especially with regard to metastasis. Whether co-NECs on the right and left sides of the colon have different characteristics from colon adenocarcinoma is unkno
Externí odkaz:
https://doaj.org/article/9b20179b591c485a8ed4555613875677
Autor:
Jingjing Li, Qing Wei, Xiaoying Wu, Jun Sima, Qi Xu, Mengmeng Wu, Fufeng Wang, Haibo Mou, Hanguang Hu, Jianguo Zhao, Da Li, Jinlin Hu, Lingnan Zhang, Xiu Zhu, Lei Chen, Cong Luo, Junrong Yan, Jiachen He, Yutong Ma, Yang Shao, Wei Wu, Jieer Ying
Publikováno v:
Clinical and Translational Medicine, Vol 10, Iss 4, Pp n/a-n/a (2020)
Abstract Background While there have been encouraging preliminary clinical results for immune checkpoint inhibitors (ICIs) in BTCs, it remains a challenge to identify the subset of patients who may benefit. In this study, we evaluated the efficacy of
Externí odkaz:
https://doaj.org/article/fc39024e233146edaa645bd4069ce501